Medicure (MCUJF) EBITDA Margin (2009 - 2026)
Medicure (MCUJF) recorded EBITDA Margin of 13.63% in the year ended Dec 31, 2025, down 20.25 percentage points from 33.88% a year earlier.
Powered by 
Analysis
Medicure (MCUJF) EBITDA Margin (2009 - 2026) Analysis & Trends
Starting with the year ended May 31, 2009, Medicure's EBITDA Margin history includes 17 years.
- Annual EBITDA Margin has declined for three straight years, though with a five-year change of +59.57 percentage points (years ended Dec 2020 to Dec 2025).
- The figure for the year ended Dec 31, 2025 is the lowest annual EBITDA Margin since the year ended Dec 31, 2021.
- Per Business Quant data, MCUJF's EBITDA Margin was 33.88% in the year ended Dec 31, 2024 (-2.32 pp), 36.20% in the year ended Dec 31, 2023 (-8.00 pp), 44.20% in the year ended Dec 31, 2022 (+39.36 pp) and 4.84% in the year ended Dec 31, 2021 (+50.78 pp).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 53.49% |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 35.95% |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 49.01% |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 6.02% |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 33.11% |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 46.01% |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | -124.26% |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 39.16% |
| 10 | Medicure | 32.46 Mn | 24.30 Mn | 2.31 Mn | -9.21% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -9.21% |
| Mar 31, 2026 | 28.16% |
| Dec 31, 2025 | 8.85% |
| Sep 30, 2025 | 19.21% |
| Jun 30, 2025 | -0.85% |
| Mar 31, 2025 | -0.15% |
| Dec 31, 2024 | 2.26% |
| Sep 30, 2024 | -11.29% |
| Jun 30, 2024 | -10.76% |
| Mar 31, 2024 | 10.22% |
| Dec 31, 2023 | -20.59% |
| Sep 30, 2023 | 12.36% |
| Jun 30, 2023 | 14.62% |
| Mar 31, 2023 | 102.51% |
| Mar 31, 2022 | 49.74% |
| Mar 31, 2021 | 55.45% |
| Mar 31, 2020 | 16.38% |
| Dec 31, 2019 | -102.48% |
| Sep 30, 2019 | -17.65% |
| Jun 30, 2019 | -10.54% |
API Access
Medicure EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=MCUJF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "MCUJF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=MCUJF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();